Skip to main content
. 2021 Feb 24;16(2):e0247591. doi: 10.1371/journal.pone.0247591

Table 3. Characteristics of all drug responses.

Panel A. Drug class Total N (%)a Correct Match N (%) Incorrect Match N (%) Indeterminate N (%) P-value
Analgesic 3,393 (36.6) 3,226 (95.1) 53 (1.6) 114 (3.4) < .0001
Antacid 35 (0.4) 25 (71.4) 6 (17.1) 4 (11.4)
Anti-asthmatic 15 (0.2) 13 (86.7) 1 (6.7) 1 (6.7)
Anti-diabetic 31 (0.3) 23 (74.2) 3 (9.7) 5 (16.1)
Antihistamines 120 (1.3) 28 (23.3) 43 (35.8) 49 (40.8)
Anti-hypertensive 334 (3.6) 293 (87.7) 25 (7.5) 16 (4.8)
Anti-malarial 462 (5.0) 444 (96.1) 15 (3.3) 3 (0.7)
Anti-spasmodic 19 (0.2) 14 (73.7) 4 (21.1) 1 (5.3)
Antibiotics 692 (7.5) 443 (64.0) 184 (26.6) 65 (9.4)
Expectorant 72 (0.8) 47 (65.3) 23 (31.9) 2 (2.8)
Haematinics 1,276 (13.8) 651 (51.0) 237 (18.6) 388 (30.4)
Herbal 1,297 (14.0) 0 (0) 0 (0) 1,297 (100.0)
Vitamins and minerals 1,520 (16.4) 460 (30.3) 511 (33.6) 549 (36.1)
Total 9,266 (100.0) 5,667 (61.2) 1,105 (11.9) 2,494 (26.9)
Panel B. Place where drug was obtained
Public clinic 366 (4.0) 242 (66.1) 58 (15.9) 66 (18.0) < .0001
Private clinic 597 (6.5) 409 (68.5) 80 (13.4) 108 (18.1)
Patent Proprietary Medicine Vendors (PPMVs) 6,695 (73.0) 4,796 (71.6) 892 (13.3) 1,007 (15.0)
Other 1,514 (16.5) 155 (10.2) 58 (3.8) 1,301 (85.9)
Total 9,172 (100.0) 5,602 (61.1) 1,088 (11.9) 2,482 (27.1)
Missing 94 65 17 12

aValue represents percentage of the total number of drugs.